MyFinsight
Home
Blog
About
Effect of exchange rate
changes on cash, cash...
$4K
(116.00%↑ Y/Y)
Net (decrease)
increase in cash, cash...
-$20,029K
(2.98%↑ Y/Y)
Canceled cashflow
$4K
Stock-based compensation
expense
$3,554K
(-10.55%↓ Y/Y)
Prepaid expenses and
other assets
-$1,778K
(-250.30%↓ Y/Y)
Accrued liabilities and
other liabilities
$1,212K
(154.16%↑ Y/Y)
Accounts payable
$652K
(1043.86%↑ Y/Y)
Non-cashlease expense
$203K
(-46.86%↓ Y/Y)
Depreciation
$184K
Non-cashinterest expense related
to term loan
$165K
(-54.42%↓ Y/Y)
Change in other, net
$130K
(4.84%↑ Y/Y)
something is missing
$4,875K
Proceeds from exercise of
stock options
$75K
(-62.12%↓ Y/Y)
Net cash used in
operating activities
-$19,760K
(34.86%↑ Y/Y)
Net cash provided by
financing activities
-$273K
(-102.80%↓ Y/Y)
Canceled cashflow
$7,878K
Canceled cashflow
$4,950K
Net loss
-$27,638K
(15.93%↑ Y/Y)
Payments of issuance cost
and underwriting...
$5,223K
Back
Back
Cash Flow
Alto Neuroscience, Inc. (ANRO)
Alto Neuroscience, Inc. (ANRO)
source: myfinsight.com